OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Allison J. Greaney, Rachel Eguia, Tyler N. Starr, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010592-e1010592
Open Access | Times Cited: 25

Showing 25 citing articles:

Learning from prepandemic data to forecast viral escape
Nicole N. Thadani, Sarah F. Gurev, Pascal Notin, et al.
Nature (2023) Vol. 622, Iss. 7984, pp. 818-825
Open Access | Times Cited: 78

The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
Alief Moulana, Thomas Dupic, Angela M. Phillips, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 50

Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 60

Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
Alexander Muik, Bonny Gaby Lui, Jasmin Quandt, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112888-112888
Open Access | Times Cited: 23

T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
Ruoxuan Sun, Mark G. Qian, Xiaobin Zhang
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9

Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8

Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Immunoinformatics-guided design of a multiepitope peptide vaccine targeting the receptor-binding domain of SARS-CoV-2 spike glycoprotein: insights from Indonesian samples
Irvan Faizal, Deepak Chandra, Tarwadi, et al.
Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics (2025)
Open Access

Designed mosaic nanoparticles enhance cross-reactive immune responses in mice
Eric Wang, Alexander A. Cohen, Luis F. Caldera, et al.
Cell (2025)
Open Access

SARS-CoV-2 Fusion Peptide-Directed Antibodies Elicited by Natural Infection Mediate Broad Sarbecovirus Neutralization
Alex Roederer, Yi Cao, Chia Jung Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
Jiansheng Jiang, Christopher T. Boughter, Javeed Ahmad, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
Craig A. Magaret, Li Li, Allan C. deCamp, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants
Thandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N. Mkhize, et al.
Journal of Virology (2022) Vol. 96, Iss. 15
Open Access | Times Cited: 13

Structural Immunology of SARSCoV‐2
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 2

Learning from pre-pandemic data to forecast viral escape
Nicole N. Thadani, Sarah F. Gurev, Pascal Notin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10

Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure
Lisa C. Lindesmith, Paul D. Brewer-Jensen, Michael L. Mallory, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1293-1293
Open Access | Times Cited: 6

SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
Jiansheng Jiang, Christopher T. Boughter, Javeed Ahmad, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2

ONE HEALTH APPROACH ON SARS-COV-2 – USING SHEEP AS SENTINEL ANIMALS TO INCREASE FUTURE PANDEMIC PREPAREDNESS – a pilot study
Milena Samojlović, João R. Mesquita, Sérgio Santos‐Silva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Indrani Das Jana, Kawkab Kanjo, Subhanita Roy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia
Alessandra Ruggiero, Sara Caldrer, Claudia Pastori, et al.
Research Square (Research Square) (2024)
Open Access

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
Craig A. Magaret, Li Li, Allan C. deCamp, et al.
Research Square (Research Square) (2023)
Open Access

Mutational basis of serum cross-neutralization profiles elicited by infection or vaccination with SARS-CoV-2 variants
Kshitij Wagh, Xiaoying Shen, James Theiler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Determinants ofde novoB cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections
Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
Alief Moulana, Thomas Dupic, Angela M. Phillips, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access

Page 1

Scroll to top